Merit Medical Systems has received 510(k) clearance for the SwiftNINJA steerable microcatheter, covering peripheral and coronary applications. With the exception of Japan, Merit has global distribution rights for the SwiftNINJA.
“For the past several months we have been marketing this unique product with great success in Europe,” said Fred P Lampropoulos, Merit’s chairman and chief executive officer. “Physician response relating to range, convenience and overall cost, when compared to the use of multiple devices, has validated our initial expectations.”
The SwiftNINJA is scheduled to be launched simultaneously with the Corvocet biopsy system, which also recently received 510(k) clearance.
“We believe these two patented and transformative technologies will provide substantial momentum and enthusiasm amongst our sales force and customers as we prepare for 2017,” Lampropoulos said.